{"id":3885,"date":"2024-11-01T16:30:12","date_gmt":"2024-11-01T16:30:12","guid":{"rendered":"https:\/\/ifx0.com\/?p=3885"},"modified":"2024-11-01T16:30:13","modified_gmt":"2024-11-01T16:30:13","slug":"nose-to-brain-delivery-of-nanoformulations-for-treatment-of-depression-focus-on-antioxidant-and-anti-inflammatory-pathways","status":"publish","type":"post","link":"https:\/\/ifx0.com\/index.php\/2024\/11\/01\/nose-to-brain-delivery-of-nanoformulations-for-treatment-of-depression-focus-on-antioxidant-and-anti-inflammatory-pathways\/","title":{"rendered":"Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression: Focus on Antioxidant and Anti-Inflammatory Pathways"},"content":{"rendered":"\n<p>Depression is commonly linked to heightened levels of pro-inflammatory markers, emphasizing the importance of addressing this aspect for effective treatment. Current treatment options encompass selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and bioactive compounds from herbal medicine with antidepressant properties. Nevertheless, ensuring adequate drug levels in the brain regions affected by depression poses a challenge. To surmount this obstacle, leveraging drug delivery systems capable of breaching the blood-brain barrier (BBB) has emerged as a promising strategy for administering antidepressants. Nanoformulations (NFs) have shown promise in this regard, facilitating the delivery of antidepressant agents. This examination offers an outline of nose-to-brain delivery using NFs for treating depression, with a focus on enhancing anti-inflammatory and antioxidant effects.<\/p>\n<p>link of study: <a href=\"https:\/\/www.igi-global.com\/chapter\/nose-to-brain-delivery-of-nanoformulations-for-treatment-of-depression\/361137\">https:\/\/www.igi-global.com\/chapter\/nose-to-brain-delivery-of-nanoformulations-for-treatment-of-depression\/361137<\/a><\/p>\n<p>to download citation file you can click the link and export it.<\/p>\n<p>cite chapter:<\/p>\n<h3>MLA<\/h3>\n<div><span id=\"ctl00_cphFeatured_ucCiteContent_lblCitationMla\">Mokhtari, Tahmineh, et al. &#8220;Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression: Focus on Antioxidant and Anti-Inflammatory Pathways.&#8221; <i>Nanomaterials and the Nervous System,<\/i> edited by Deniz Eren Erisen, et al., IGI Global, 2025, pp. 245-274. https:\/\/doi.org\/10.4018\/979-8-3693-3065-4.ch009<\/span><\/div>\n<h3>APA<\/h3>\n<div><span id=\"ctl00_cphFeatured_ucCiteContent_lblCitationApa\">Mokhtari, T., Sheikhbahaei, F., Saadat, M., &amp; Uludag, K. (2025). Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression: Focus on Antioxidant and Anti-Inflammatory Pathways. In D. Erisen, K. Uludag, &amp; N. Ahmad (Eds.), <i>Nanomaterials and the Nervous System<\/i> (pp. 245-274). IGI Global. https:\/\/doi.org\/10.4018\/979-8-3693-3065-4.ch009<\/span><\/div>\n<h3>Chicago<\/h3>\n<div><span id=\"ctl00_cphFeatured_ucCiteContent_lblCitationChicago\">Mokhtari, Tahmineh, et al. &#8220;Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression: Focus on Antioxidant and Anti-Inflammatory Pathways.&#8221; In <i>Nanomaterials and the Nervous System,<\/i> edited by Deniz Eren Erisen, Kadir Uludag, and Nafees Ahmad, 245-274. Hershey, PA: IGI Global, 2025. https:\/\/doi.org\/10.4018\/979-8-3693-3065-4.ch009<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Depression is commonly linked to heightened levels of pro-inflammatory markers, emphasizing the importance of addressing this aspect for effective treatment. Current treatment options encompass selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and bioactive compounds from herbal medicine with <a href=\"https:\/\/ifx0.com\/index.php\/2024\/11\/01\/nose-to-brain-delivery-of-nanoformulations-for-treatment-of-depression-focus-on-antioxidant-and-anti-inflammatory-pathways\/\" class=\"read-more\">Read More &#8230;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3885","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts\/3885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/comments?post=3885"}],"version-history":[{"count":1,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts\/3885\/revisions"}],"predecessor-version":[{"id":3886,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts\/3885\/revisions\/3886"}],"wp:attachment":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/media?parent=3885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/categories?post=3885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/tags?post=3885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}